Loading the company…
Loading the company…
Families: Debridement & negative-pressure wound therapy.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Cork Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2026 (1). The latest was on 2026-05-21.
| Family | Decisions on record |
|---|---|
| Debridement & negative-pressure wound therapy | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-05-21 | 510(k) | K261291 | Nisus NPWT Canister 500-mL (CPC-500) |
| 2025-06-27 | 510(k) | K243187 | Nisus ONE Negative Pressure Wound Therapy System (OCMPP-100) |
| 2024-08-21 | 510(k) | K241061 | VERSA Negative Pressure Wound Therapy System (VCMPP-100) |
| 2023-12-06 | 510(k) | K230677 | Cork Medical VERSA Negative Pressure Wound System (VCMPP-100) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Cork Medical.